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Night-time immobilization of the distal
interphalangeal joint reduces pain and extension
deformity in hand osteoarthritis
Fiona E. Watt1,2, Donna L. Kennedy3, Katharine E. Carlisle3, Andrew J. Freidin1,
Richard M. Szydlo4, Lesley Honeyfield5, Keshthra Satchithananda5,6 and
Tonia L. Vincent1,2
Abstract
Objective. DIP joint OA is common but has few cost-effective, evidence-based interventions. Pain and
deformity [radial or ulnar deviation of the joint or loss of full extension (extension lag)] frequently lead to
functional and cosmetic issues. We investigated whether splinting the DIP joint would improve pain,
function and deformity.
Methods. A prospective, radiologist-blinded, non-randomized, internally controlled trial of custom splint-
ing of the DIP joint was carried out. Twenty-six subjects with painful, deforming DIP joint hand OA gave
written, informed consent. One intervention joint and one control joint were nominated. A custom gutter
splint was worn nightly for 3 months on the intervention joint, with clinical and radiological assessment at
baseline, 3 and 6 months. Differences in the change were compared by the Wilcoxon signed rank test.
Results. The median average pain at baseline was similar in the intervention (6/10) and control joints
(5/10). Average pain (primary outcome measure) and worst pain in the intervention joint were significantly
lower at 3 months compared with baseline (P= 0.002, P= 0.02). Differences between intervention and
control joint average pain reached significance at 6 months (P= 0.049). Extension lag deformity was sig-
nificantly improved in intervention joints at 3 months and in splinted joints compared with matched
contralateral joints (P= 0.016).
Conclusion. Short-term night-time DIP joint splinting is a safe, simple treatment modality that reduces DIP
joint pain and improves extension of the digit, and does not appear to give rise to non-compliance,
increased stiffness or joint restriction.
Trial registration: clinical trials.gov, http://clinicaltrials.gov, NCT01249391.
Key words: osteoarthritis, splint, pain, non-pharmacological therapy, distal, interphalangeal.
Introduction
Hand OA affects 5570% of the adult population
>55 years of age, and DIP joint disease is one of the
most common manifestations [1]. Episodes of severe
pain or persistent pain and sensitivity to minor knocks
are common, contributing to hand dysfunction [2].
Deformity, either radial or ulnar deviation at the joint or
loss of full extension (extension lag), is common.
Functional deficits and reduced quality of life are well
documented in those with DIP joint disease, particularly
when associated with other hand joint involvement [24].
Aesthetic concerns from hand OA also cause
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considerable distress and their presence correlates with
reduced health-related quality of life [5].
The current burden of symptomatic DIP joint OA partly
reflects the lack of effective options, both pharmaco-
logical and non-pharmacological, for this disease. Flares
and persistent pain at the DIP joint are often poorly re-
sponsive to existing analgesics such as paracetamol, oral
NSAIDs, or topical NSAIDs or capsaicin. Many clinicians
feel steroid injection to the DIP joint is ill-advised, although
no controlled studies have been carried out to our know-
ledge. Ultimately, for very symptomatic joints, DIP joint
surgical fusion remains a last resort [6].
Mechanical factors and local inflammation appear im-
portant in the initiation of symptoms and progression at
any given site in OA. Elegant high-resolution MRI studies
in hand OA have shown that collateral ligaments and bony
entheses are implicated in DIP joint disease, with inflam-
matory changes visible in these structures in early and
established disease [7, 8]. In acute soft tissue injuries of
the DIP joint such as capsular injuries, collateral ligament
sprains and tendon avulsion injuries, splinting is routinely
used to immobilize healing structures, restoring joint
stability and mobility within 12 weeks [9, 10]. Pre-clinical
studies by our group suggest that immobilisation of a sur-
gically injured joint abrogates the development of OA [11].
In hand OA there is good evidence from small clinical trials
that splinting of the first CMC joint improves pain and
function and reduces the need for surgery [1216].
Anecdotally, we and others have found that splinting of
the DIP joint appears to be beneficial in painful interpha-
langeal OA. We investigated whether custom thermoplas-
tic splinting improves pain, function and deformity of the
affected DIP joint and thus might prove a useful therapy
for treating OA at this site.
Methods
Ethics
Approval was granted by the West London Research
Ethics Committee 3 for this clinical trial (REC reference
10/H0706/44). The trial was registered on clinicaltrials.gov
(NCT01249391). All participants gave written informed
consent to participate prior to screening, according to
the Declaration of Helsinki.
Study design and subjects
A non-randomized, radiologist-blinded controlled trial
was conducted. Participants were patients attending a
specialist rheumatology hand clinic at Charing Cross
Hospital, Imperial College Healthcare NHS Trust,
London, UK. Inclusion criteria were age518 years, a def-
inite diagnosis of hand OA according to ACR criteria [17],
evidence of radiographic OA, at least two eligible DIP
joints and stable therapies such as NSAIDs for the pre-
ceding 4 weeks. Eligible DIP joints for the purposes of this
study were defined as those with radiographic OA, pain
52 (of 10) on a numerical rating scale (NRS) over the last
7 days and the presence of deformity, defined as at least
7 of radial/ulnar deviation deformity at the joint, with or
without loss of full active extension of the joint (extension
lag; see Fig. 1A). Exclusion criteria were inflammatory
arthritis or other diagnosis contributing to hand pain, a
history of psoriasis, planned hand surgery or expected
changes to therapy, or IA or systemic corticosteroids in
the preceding 3 months, or IA hyaluronans in the preced-
ing 6 months.
Procedure
During screening, between two and four eligible joints
were identified for observation (see above). Of these, an
intervention joint was nominated by the patient and clin-
ician to receive a splint. This was a single troublesome,
symptomatic joint and could be on either the dominant or
non-dominant hand. The other eligible joints were fol-
lowed as control joints: one of these joints was identified
by the clinician (patient and hand therapist blinded) as the
nominated control joint, based on specific criteria (in order
of preference: similar level of pain as the intervention joint,
the same digit on the contralateral hand, an adjacent joint
on the contralateral hand, etc.). No placebo was included,
as there is no accepted placebo or sham for splinting. A
custom gutter thermoplastic splint was made by a senior
hand therapist for each subject’s intervention joint at their
baseline visit, following assessments (Fig. 1B). Patients
were shown how to fit the splint and were asked to
wear it every night (for at least 6 and no more than 12 h)
for 3 months. Splinting was then discontinued (patients
were requested to stop use) and subjects were seen
after a further 3 months. A phone call at 2 weeks to as-
certain splint comfort and compliance was made, with
early review if necessary. Patient-reported adherence to
nightly splinting was recorded following questioning at
each subsequent study visit. Patients were asked not to
alter their pain relief and other hand therapies during the
study if possible and any changes were documented at
each visit. Anteroposterior radiographs of each of the
nominated study digits were acquired prior to initiation
of splinting at baseline and the same digits were reimaged
at 3 and 6 months (Fig. 1C).
Outcome measures
The primary outcome measure was average pain in
the nominated joints at 3 months. Primary and all second-
ary outcome measures were recorded at baseline, 3 and
6 months (by the same senior hand therapist or
rheumatologist).
Pain
Average pain over the preceding week (primary outcome)
and worst pain over the preceding week in nominated
joints were recorded. The participant was asked to read
a standardized question for each and circled a number on
an NRS, with anchors of no pain (0) and pain as bad as it
can be (10), as recommended in the OARSI guidelines for
OA trials [18].
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Disease activity
Tender joint score (1 or 0) for nominated joints was re-
corded by a rheumatologist. Swelling was measured by
joint circumference (in millimetres). Stiffness was recorded
in minutes.
Functional ability
Pain-free pinch of the nominated joint (in kilograms) was
measured with the Biometric E-Link Evaluation System
V900S (Biometrics, Gwent, UK). The Biometric E-Link
Evaluation System is a calibrated, computerized system
incorporating a modified pinch gauge, measuring strength
to the tenth of a kilogram (mean of three measurements).
The total active range of motion at the DIP joint (degrees)
and extension lag (degrees of loss of full extension of the
DIP joint on active extension) was measured by goniom-
eter. The range of motion of the PIP and MCP joints of the
same digit were also measured. Measurement methods
for range, extension, etc. were standardized between
therapists and followed American Society of Hand
Therapists’ guidelines [19].
Joint deformity
The radial or ulnar deviation of each DIP joint was mea-
sured by goniometer (degrees). Anteroposterior plain
radiograph of each nominated digit was performed at
baseline, 3 and 6 months (Fig. 1C). Radiographic deviation
(radial or ulnar) was measured by a consultant radiologist
blinded to the intervention joint (degrees). All measure-
ments were repeated, blinded to the first reading, at a
later date by the same radiologist. All films were also in-
dependently measured by another reader (Spearman’s R
coefficient 0.82).
Patient-oriented outcomes
The HAQ, 12-item Short Form (SF-12) and Michigan hand
questionnaire (MHQ) were completed at all visits. The
MHQ is a self-administered, 37-item questionnaire mea-
suring symptoms and physical function relating to hand
and wrist disorders that has been validated in hand OA
[20]. The questionnaire was selected because it contains
various domains including aesthetic concerns. The score
ranges for each hand from 0 to 100, where 0 is maximum
disability and 100 is minimum disability. At the end of the
study, patients were asked to give a global rating of
change regarding whether the intervention finger joint
was worse, unchanged or improved compared with the
start of the study [21]. They were also asked if they
would want to continue the intervention beyond the end
of the study.
Statistical analyses
Power calculation yielded a target sample size of 22 sub-
jects to detect a difference of 2 points on the NRS for
FIG. 1 Custom thermoplastic gutter splinting of the DIP joint
(A) An example of an extension lag deformity of the distal IP joint prior to splinting. There is incomplete extension at the
joint on attempted active extension by the individual. (B) Splints were fabricated from thermoplastic by a senior hand
therapist and adjusted at 6 weeks if necessary to ensure comfort and fit. An example is shown. (C) Anteroposterior plain
radiograph of a digit from a study subject showing an affected middle finger DIP joint on the right hand. Evidence of
radiographic change consistent with OA of the joint is present and there is also radial deviation deformity.
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average pain with 90% power to detect a statistically sig-
nificant difference at the 5% level. A change of 1 point on
this scale represents the minimum clinically important dif-
ference, and a reduction of 2 points represents a feeling of
being much improved, which has been employed in other
hand OA trials [18, 22]. Changes in the intervention joint
and nominated control joint for each subject at 3 and 6
months were calculated by subtracting the baseline score
from the scores at either 3 months or 6 months for each
digit respectively, and were assessed by the Wilcoxon
signed rank test. Differences in change in control and
intervention joints at 3 and 6 months (control joint
change subtracted from intervention joint change) were
assessed by the Wilcoxon signed rank test. P-values
<0.05 were considered statistically significant. Data ana-
lysis was performed using the SPSS version 20 (IBM,
Armonk, NY, USA).
Results
Study population characteristics
Twenty-six subjects were enrolled in the study. Primary
outcome data were available for 23 subjects at
3 months and 22 subjects completed all study visits
(2 subjects withdrew after the baseline visit, and there
were 2 later withdrawals: 1 patient dropped out for per-
sonal reasons (bereavement), 2 because of the need for
hand surgery/steroid injection for a non-study joint and
only 1 because of intolerance to wearing a splint).
Subject characteristics at baseline are shown in Table 1.
Their median HAQ, SF-12 and MHQ scores suggested
substantial impairment. There was no significant differ-
ence in average pain between the nominated intervention
and control joints at baseline (P= 0.12) (Table 2).
Intervention joints were on the dominant hand in about
half (12 of 23) of the subjects who completed the
3 month assessment. Of those completing the 3 month
assessment, nine patients had a perfect match control
(same digit on opposite hand). A further nine had an alter-
native digit control on the opposite hand. At 2 weeks, one
patient required refabrication of their splint to improve fit
and comfort. At the 6 week review, a further six patients
had minor modifications to improve splint fit. Poor adher-
ence to nightly splinting was reported by only four sub-
jects and this was improved following splint adjustment in
all but one subject by 6 weeks (data not shown). Only one
patient reported changes in their usual treatment during
the intervention period (switch in analgesic). Replication of
the analyses without this subject did not affect the results
(data not shown).
Sustained reduction in DIP joint pain after splinting
The average pain reported by subjects over the preceding
week (primary outcome measure) was significantly lower
in the intervention joint at 3 months compared with base-
line (Table 2 and Fig. 2A). This outcome did not appear to
be dependent on whether the intervention joint was on the
dominant or non-dominant hand (NRS reduced by a
median of 1.5 in both groups). The worst pain in the
intervention joint in the preceding week was also signifi-
cantly reduced at 3 months (P= 0.02). Ten of 23 (43%)
patients had a reduction of 52 points on the NRS at
3 months in intervention joint average pain, compared
with a similar reduction in only 5 of 23 control joints.
When the change in pain in the intervention and control
joints was compared at 3 months, differences did not
reach significance (Fig. 2B). However, in the 22 patients
completing the 6 month visit, the median average pain
score in the intervention joint was 2 points lower than
baseline and pain was significantly less than in the control
joints (P= 0.049) (Fig. 2B and C). In a planned subgroup
analysis, those who had a contralateral perfect match
control digit were assessed. In this group, intervention
joint average pain was significantly lower than the control
joint at 3 months (P= 0.035) (Fig. 2D), supporting the val-
idity of these findings.
Effect of DIP joint splinting on disease activity and
functional ability
Intervention joints were less tender at both 3 and
6 months, although the differences did not reach statis-
tical significance when compared with controls (Table 2).
The difference in stiffness of intervention joints and control
joints only approached significance at 6 months
(P= 0.058) (Table 2). No difference was seen at 3 or
6 months in joint circumference, pinch grip strength or
total range of motion of the DIP joint (Table 2). There
was also no difference in HAQ or SF-12 scores over the
course of the study period. Of the 18 patients who had
intervention and control joints on opposite hands, there
was no difference between MHQ scores for intervention
and control hands. There was no evidence of reduced
range of motion in the splinted joint or adjacent PIP
or MCP joints, which was a theoretical concern when
immobilising a joint, even on a nightly basis (data not
shown).
TABLE 1 Baseline characteristics of the study population
Characteristic
Median (range)
or n (%)
Age, years 63 (5178)
Females 23 (88)
Time from diagnosis, years 5.3 (0.320)
Body mass index, kg/m2 25.8 (18.633.5)
Right hand dominant 20 (77)
OA at other (non-hand) sites 12 (46)
Health Activity Questionnaire 1.19 (02.3)
SF-12 MCS 42.6 (23.161.2)
PCS 36.0 (19.457.3)
Total Michigan Hand
Questionnaire score
47.9 (18.885.4)
MCS: mental health component score; PCS: physical health
component score.
www.rheumatology.oxfordjournals.org 1145
Splinting DIP joints reduces pain and deformity in OA
Sustained improvement in extension lag deformity
by DIP joint splinting
In all but 2 of 26 subjects at baseline, the radial or ulnar
deviation deformity was passively correctable by at least
5 (median correction 10, range 315), suggesting that
splinting might achieve correction. The change in joint
deviation on plain radiograph (radiologist blinded to the
intervention digit) approached significance at 3 months
(P= 0.076). Similarly, clinical measurement of resting
joint deviation showed a trend towards improvement at
6 months, but did not reach significance (P= 0.057).
It should be noted that clinical and radiological measures
of deviation only correlated moderately with each other
(Pearson R= 0.63, P< 0.0001).
Extension lag deformity (a flexion deformity at the DIP
joint) occurred frequently, with all except one patient
having at least 8 at baseline. The change in intervention
joint extension lag at 3 months compared with baseline is
shown in Fig. 3A, and was significantly improved by 6
months (P= 0.039) (Fig. 3B). This change did not reach
significance when compared with controls for the whole
study population (P= 0.075). However, in the planned sub-
group analysis comparing intervention joints with same-
joint controls on the contralateral hand, extension lag was
significantly improved in intervention joints at 3 months
(P= 0.016) (Fig. 3C).
Changes perceived by patients
Of the 23 patients who completed the study, 17 (74%)
reported overall improvement following the intervention
and 14 (61%) wanted to continue use of the splint
beyond the study. Importantly, there was no reported in-
crease in stiffness in the DIP joint or adjacent joints on the
same digit. Post hoc testing of aesthetic domains for the
MHQ for the 18 subjects who had intervention and control
joints on opposite hands did not show any change over
the trial period (data not shown).
Discussion
To our knowledge this is the first trial of custom splinting in
IP joint OA or any form of chronic IP joint arthritis. Our
results suggest that short-term night-time DIP joint splint-
ing is a simple treatment modality that reduces DIP joint
pain and also appears to improve extension deformity.
Interestingly, the effects were sustained, and even
increased beyond the use of the orthotic, suggesting
that such devices may have symptom- and disease-
modifying properties. Splinting does not, if carried out
nightly for a restricted period of time, seem to give rise
to non-compliance, increased stiffness or restriction of
range of motion. Splinting for 24 h may have brought
about a greater change in outcomes, but is less likely to
have been well tolerated and may have led to a stiffer
joint. The study does not answer how long nightly splinting
can safely be continued, or whether there is an optimum
length of time for splinting. Anecdotally, several of our
patients continue to use these DIP joint splints on an inter-
mittent basis with ongoing benefit. Ikeda et al. [23]T
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reported a case series of patients where a prefabricated
plastic sleeve led to improvement in reported pain in hand
OA. Our trial differs in several important respects: the
study population had deforming disease; custom, adjust-
able splinting was employed; and control joints were
monitored in the study, as a means of internal control.
The reasons for splinting ameliorating pain are not well
understood, but are thought to result in part from joint
protection from ongoing aggravating mechanical factors,
with resulting reduction in inflammation or promotion of
tissue healing, as seen in joint distraction [24].
Design of non-pharmacological studies in hand OA is
challenging. The lack of a suitable placebo intervention to
which investigator and patient are blinded is a recognized
issue in this type of study. Devices such as tubi-grip or
digi-sleeves were considered but may have acted to
immobilize and increase joint awareness and thus were
not felt to be appropriate control or sham arms. This
was a pragmatic trial and, as such, we chose to treat a
single troublesome, symptomatic joint rather than identify
a joint by randomization. However, identifying a similar
control joint in all patients proved to be challenging.
Hand OA is often thought of as a symmetrical disease,
but as our subanalysis demonstrates, only nine patients
had eligible contralateral same-joint controls, and for
some subjects there was a larger-than-ideal difference
in levels of pain and other secondary measures between
intervention and nominated control joints at baseline
(although no difference overall between groups). It is pos-
sible that the trend towards worse pain in the selected
intervention joints could have introduced a bias, favouring
response. However, it is difficult to be sure that a less
painful control joint would necessarily be less responsive
to change than a more painful joint: there is little evidence
to support this. Large changes over the study period were
observed in control joints for some measures, highlighting
the natural history of this disease. Such differences may
represent different stages of disease in different joints,
which could make an intervention effect harder to
detect. The fact that the controls were within-participant
and simultaneously monitored meant that they were not
independent of the intervention joint. This is arguably a
FIG. 2 Reduction in pain in DIP joints by splinting
For each subject number (pnos), patient-reported pain scores in the intervention joint (int) and control joint (cont) were
recorded by a numerical rating scale (010). (A and D) The change in pain scores in the intervention joint at 3 months: the
pain at baseline is subtracted from the pain at 3 months. A negative value suggests an improvement in pain. (A) The
change in average pain in the intervention joint at 3 months (primary outcome) (P= 0.002). (B) Summary of the median
change in average pain from baseline to 3 and 6 months (*P= 0.049). (C) The difference in average pain between the
intervention and control joints at 6 months is shown for all participants. A negative value suggests more improvement in
the intervention joint than the control joint (P= 0.049). (D) The change in average pain in the intervention joint at 3 months
is shown in a predefined subgroup (n= 9) with a perfect match control joint on the opposite hand (P= 0.035).
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strength of the study and intentionally attempts to control
for disease fluctuations within the individual over time. The
trial was powered to detect a difference in average pain
over a 3 month period and it is likely that a far larger
population would be required to fully explore the effects
of splinting on some of the other selected secondary out-
comes. The lack of change in global measures such as the
SF-12, HAQ and MHQ was perhaps not surprising where
only a single joint was treated and other affected hand
joints were present. Validated responsive measures
for single joint assessment would be of value for future
clinical trials of this nature.
These participants were selected because of estab-
lished, often advanced hand OA. Given our findings, it
would be of interest to assess splinting in early hand
OA, at the time of initial pain, soft tissue change and
early/correctable deformity. This would arguably be at a
more modifiable point in the disease. DIP joints were se-
lected for this current study for a number of reasons. PIP
joint OA is reported to give rise to even greater functional
deficits and symptoms can be difficult to manage, and
splinting may be less well tolerated at this site [2].
The study demonstrates that small clinical trials can be
effective in demonstrating clinically important effects.
A larger trial would have required a multicentre approach,
which might be challenging because of the bespoke
nature of the orthotic. This would be necessary if more
restrictive criteria or subgroup analysis were to be at-
tempted. An alternative would be a prefabricated splint,
available in different sizes. However, in our experience,
good comfort and fit is unlikely to be achieved using a
prefabricated rigid splint in anything other than very
early disease, given the inherent joint deformity, and this
would lead to poor compliance. Some of the benefits in
this study may have arisen because of the ability to adjust
individual splints during the splinting period as joint
correction occurred.
Conclusion
Custom thermoplastic splinting of the DIP joint in painful,
deforming hand OA improves pain and, to a lesser extent,
extension lag deformity. These findings would justify the fur-
ther assessment of night-time splinting in larger studies as a
routine therapeutic option for both distal and PIP joint OA.
FIG. 3 Improvement in extension lag deformity in DIP joints by splinting
For each subject number (pnos), the degrees of incomplete extension on attempted active extension (ext lag) were
recorded for the intervention joint and control joint. A positive value suggests an improvement in deformity and a negative
value suggests a deterioration. (A) The change in extension lag deformity in the intervention joint at 3 months. The lag at
baseline is subtracted from the lag at 3 months (P= 0.096). (B) Summary of median change in extension lag deformity
from baseline to 3 and 6 months. *P= 0.039 in intervention joints only. (C) The change in extension lag deformity at 3
months in control joints (clear circles) and in intervention joints (black circles) in a predefined subgroup with a perfect
match control on the opposite hand (n= 9; P= 0.016).
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Rheumatology key messages
. Night-time thermoplastic splinting of osteoarthritic
DIP joints improves pain and extension lag
deformity.
. IP joint splinting is a well-tolerated, novel, joint-spe-
cific treatment for hand OA and should be explored
in larger clinical trials.
Acknowledgements
We thank Marie Kelleher and Christine Greig for study
administration. The Arthritis Research UK Centre for OA
Pathogenesis is supported by Arthritis Research UK (grant
number 20205).
Funding: This work was supported by the National
Institute of Health Research Biomedical Research
Centre, (Imperial College London), grant number P31564.
Disclosure statement: The authors have declared no
conflicts of interest.
References
1 Dahaghin S, Bierma-Zeinstra SM, Reijman M et al.
Prevalence and determinants of one month hand pain and
hand related disability in the elderly (Rotterdam study).
Ann Rheum Dis 2005;64:99104.
2 Bagis S, Sahin G, Yapici Y et al. The effect of hand
osteoarthritis on grip and pinch strength and hand func-
tion in postmenopausal women. Clin Rheumatol 2003;22:
4204.
3 Kjeken I, Dagfinrud H, Slatkowsky-Christensen B et al.
Activity limitations and participation restrictions in women
with hand osteoarthritis: patients’ descriptions and asso-
ciations between dimensions of functioning. Ann Rheum
Dis 2005;64:16338.
4 Slatkowsky-Christensen B, Mowinckel P, Loge JH et al.
Health-related quality of life in women with symptomatic
hand osteoarthritis: a comparison with rheumatoid arthritis
patients, healthy controls, and normative data. Arthritis
Rheum 2007;57:14049.
5 Hodkinson B, Maheu E, Michon M et al. Assessment and
determinants of aesthetic discomfort in hand osteoarth-
ritis. Ann Rheum Dis 2012;71:459.
6 Olivier LC, Gensigk F, Board TN et al. Arthrodesis of the
distal interphalangeal joint: description of a new technique
and clinical follow-up at 2 years. Arch Orthop Trauma Surg
2008;128:30711.
7 Tan AL, Toumi H, Benjamin M et al. Combined high-
resolution magnetic resonance imaging and histological
examination to explore the role of ligaments and tendons
in the phenotypic expression of early hand osteoarthritis.
Ann Rheum Dis 2006;65:126772.
8 Tan AL, Grainger AJ, Tanner SF et al. A high-resolution
magnetic resonance imaging study of distal interphalan-
geal joint arthropathy in psoriatic arthritis and osteoarth-
ritis: are they the same? Arthritis Rheum 2006;54:132833.
9 Liss FE, Green SM. Capsular injuries of the proximal
interphalangeal joint. Hand Clin 1992;8:75568.
10 Tuttle HG, Olvey SP, Stern PJ. Tendon avulsion injuries of
the distal phalanx. Clin Orthop Relat Res 2006;445:15768.
11 Burleigh A, Chanalaris A, Gardiner MD et al. Joint immo-
bilization prevents murine osteoarthritis and reveals the
highly mechanosensitive nature of protease expression
in vivo. Arthritis Rheum 2012;64:227888.
12 Weiss S, LaStayo P, Mills A et al. Prospective analysis of
splinting the first carpometacarpal joint: an objective,
subjective, and radiographic assessment. J Hand Ther
2000;13:21826.
13 Day CS, Gelberman R, Patel AA et al. Basal joint
osteoarthritis of the thumb: a prospective trial of ster-
oid injection and splinting. J Hand Surg Am 2004;29:
24751.
14 Boustedt C, Nordenskiold U, Lundgren Nilsson A. Effects
of a hand-joint protection programme with an addition of
splinting and exercise: one year follow-up. Clin Rheumatol
2009;28:7939.
15 Rannou F, Dimet J, Boutron I et al. Splint for base-of-
thumb osteoarthritis: a randomized trial. Ann Intern Med
2009;150:6619.
16 Zhang W, Doherty M, Leeb BF et al. EULAR evidence
based recommendations for the management of hand
osteoarthritis: report of a task force of the EULAR
Standing Committee for International Clinical Studies
Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;
66:37788.
17 Altman R, Alarcon G, Appelrouth D et al. The American
College of Rheumatology criteria for the classification and
reporting of osteoarthritis of the hand. Arthritis Rheum
1990;33:160110.
18 Maheu E, Altman RD, Bloch DA et al. Design and conduct
of clinical trials in patients with osteoarthritis of the hand:
recommendations from a task force of the Osteoarthritis
Research Society International. Osteoarthritis Cartilage
2006;14:30322.
19 Garner NC. Clinical Assessment Recommendations.
Mount Laurel, NJ, USA: American Society of Hand
Therapists, 1981.
20 McPhail SM, Bagraith KS, Schippers M et al. Use of
condition-specific patient-reported outcome measures in
clinical trials among patients with wrist osteoarthritis: a
systematic review. Adv Orthop 2012;2012:273421.
21 Kamper SJ, Maher CG, Mackay G. Global rating of change
scales: a review of strengths and weaknesses and con-
siderations for design. J Man Manip Ther 2009;17:16370.
22 Salaffi F, Stancati A, Silvestri CA et al. Minimal clinically
important changes in chronic musculoskeletal pain inten-
sity measured on a numerical rating scale. Eur J Pain
2004;8:28391.
23 Ikeda M, Ishii T, Kobayashi Y et al. Custom-made splint
treatment for osteoarthritis of the distal interphalangeal
joints. J Hand Surg 2010;35:58993.
24 Intema F, Van Roermund PM, Marijnissen AC et al. Tissue
structure modification in knee osteoarthritis by use of joint
distraction: an open 1-year pilot study. Ann Rheum Dis
2011;70:14416.
www.rheumatology.oxfordjournals.org 1149
Splinting DIP joints reduces pain and deformity in OA
